Bowenoid change in association with graft-versus-host disease: A cyclosporine toxicity?
- 31 December 1994
- journal article
- case report
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 31 (6) , 1052-1054
- https://doi.org/10.1016/s0190-9622(09)80082-0
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Cutaneous malignancy related to cyclosporin A therapyClinical and Experimental Dermatology, 1993
- Clinical, Laboratory, and Histopathologic Indicators of the Development of Progressive Acute Graft-Versus-Host DiseaseJournal of Investigative Dermatology, 1992
- A Review of Assay Methods for CyclosporinClinical Pharmacokinetics, 1992
- A retrospective analysis of therapy for acute graft-versus-host disease: initial treatmentBlood, 1990
- Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprineBritish Journal of Dermatology, 1989
- Cyclosporin A and Graft-vs.-Host DiseaseThe American Journal of Dermatopathology, 1986
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974